Skip Ribbon Commands
Skip to main content
Menu
Dr Jeffrey Quek

Dr Quek Kim Siang Jeffrey

MBBS, MRCP (UK)

Consultant

Singapore General Hospital

Specialty: Haematology

Sub-specialties: Haematopoietic Stem Cell & Cellular Therapy

Conditions Treated by this Doctor:
Acute Lymphocytic Leukemia (ALL), Aplastic Anaemia, Chronic lymphocytic leukemia, Chronic Myeloid Leukemia (CML), Deep Vein Thrombosis, Deep Vein Thrombosis, essential thrombocythemia, Multiple Myeloma, Myelodysplastic Syndromes, Myelofibrosis, Polycythemia Vera, Thalassaemia.

Clinical Appointments

  • Consultant SingHealth Duke-NUS Blood Cancer Centre
  • Consultant SingHealth Duke-NUS Transplant Centre
  • Consultant Haematology Singapore General HospitalSingapore General Hospital

Profile

​Dr Jeffrey Quek graduated from School of Medicine, National University of Singapore (NUS) in 2007. He obtained his MRCP(UK) in 2013. He underwent Senior Residency Training in Haematology in Singapore General Hospital (SGH) from 2013 to 2016. He is currently a Consultant with the Department of Haematology, SGH. He is also appointed as Member of the Medical Review Panel of the Bone Marrow Donor Programme (BMDP). He is actively involved in clinical services, clinical trials and education. His area of interests are in hematopoietic stem cell transplantation and acute leukemias. 

Education

  • ​MBBS
  • MRCP (UK)

Professional Appointments and Committee Memberships

  • Clinical Lecturer, Yong Loo Lin School of Medicine, National University of Singapore
  • Clinical Teacher, Lee Kong Chian School of Medicine
  • Clinical Assistant Professor, Duke-NUS Medical School
  • Member of the Medical Review Panel, Bone Marrow Donor Program Singapore (BMDP) 
  • Executive Committee Member, Singapore Society of Haematology

Awards

  • Singhealth 10-year Long Service Award 2019
  • ​Outstanding Residency Award 2014
  • Outstanding Residency Award 2015
  • Singhealth Quality service award – Silver Award 2013-2014
  • Singhealth Quality service award – Gold Award 2014 – 2015
  • Singhealth Quality service award – Star Award 2015- 2016

Research Interests

Publications

  • Pwint K-SW, Chen Y, Diong CP, Goh Y-T, Grant D, Ho A, et al. Mobilization kinetics of peripheral blood stem cells with rescue plerixafor - real-world experience from a single center. Vol. 61, Leukemia & lymphoma. United States; 2020. p. 1740–3.
  • Quek J, Lee JJ, Lim FL, Diong C, Goh YT, Gopalakrishnan S, et al. Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant. Transfusion. 2019 Jan;59(1):335–9.
  • Lee LY, Namuduri R, Chan MMF, Quek JKS, Koh MJ-A. Epstein-Barr virus positive diffuse large B-cell lymphoma presenting with vaginal sloughing and ulcerated skin nodule. Vol. 45, Journal of cutaneous pathology. United States; 2018. p. 162–6.
  • Acquired factor V deficiency in a patient with myeloma and amyloidosis. Quek JKS, Wong WH, Tan CW, Tha MH, Nagarajan C, Lee LH, Ng HJ. Thromb Res. 2018 Jan 31;164:1-3. doi: 10.1016/j.thromres.2018.01.045
  • Yeap WH, Wong KL, Shimasaki N, Teo ECY, Quek JKS, Yong HX, et al. Corrigendum: CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2017 Apr;7:46202.
  • Yeap WH, Wong KL, Shimasaki N, Teo ECY, Quek JKS, Yong HX, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016 Sep;6:34310. 

Research Trials